Did you mean: nathalie nicolas

Search results - 3 results

Effectiveness of XBB.1.5 Monovalent COVID-19 Vaccines During a Period of XBB.1.5 Dominance in EU/EEA Countries, October to November 2023: A VEBIS-EHR Network Study.

https://www.sciensano.be/en/biblio/effectiveness-xbb15-monovalent-covid-19-vaccines-during-a-period-xbb15-dominance-eu-eea-countries

Publication Type: Peer reviewed scientific article Authors: Monge, Susana; Humphreys, James; Nicolay, Nathalie; Toon Braeye; Izaak Van Evercooren; Holm Hansen, Christian; Emborg, Hanne-Dorthe; ...

Relative vaccine effectiveness against COVID-19 hospitalisation in persons aged ≥ 65 years: results from a VEBIS network, Europe, October 2021 to July 2023.

https://www.sciensano.be/en/biblio/relative-vaccine-effectiveness-against-covid-19-hospitalisation-persons-aged-65-years-results-a

Publication Type: Peer reviewed scientific article Authors: Fontán-Vela, Mario; Kissling, Esther; Nicolay, Nathalie; Toon Braeye; Izaak Van Evercooren; Holm Hansen, Christian; Emborg, Hanne-Dorthe; ...

Monovalent XBB.1.5 COVID-19 vaccine effectiveness against hospitalisations and deaths during the Omicron BA.2.86/JN.1 period among older adults in seven European countries: A VEBIS-EHR network study.

https://www.sciensano.be/en/biblio/monovalent-xbb15-covid-19-vaccine-effectiveness-against-hospitalisations-and-deaths-during-omicron

Publication Type: Peer reviewed scientific article Authors: Nunes, Baltazar; Humphreys, James; Nicolay, Nathalie; Toon Braeye; Izaak Van Evercooren; Holm Hansen, Christian; Moustsen-Helms, Ida Rask; ...

Search results - 3 results

Effectiveness of XBB.1.5 Monovalent COVID-19 Vaccines During a Period of XBB.1.5 Dominance in EU/EEA Countries, October to November 2023: A VEBIS-EHR Network Study.

Relative vaccine effectiveness against COVID-19 hospitalisation in persons aged ≥ 65 years: results from a VEBIS network, Europe, October 2021 to July 2023.

Monovalent XBB.1.5 COVID-19 vaccine effectiveness against hospitalisations and deaths during the Omicron BA.2.86/JN.1 period among older adults in seven European countries: A VEBIS-EHR network study.

QR code

Sciensano info

Postal address

Search form

Search results - 3 results

Effectiveness of XBB.1.5 Monovalent COVID-19 Vaccines During a Period of XBB.1.5 Dominance in EU/EEA Countries, October to November 2023: A VEBIS-EHR Network Study.

Relative vaccine effectiveness against COVID-19 hospitalisation in persons aged ≥ 65 years: results from a VEBIS network, Europe, October 2021 to July 2023.

Monovalent XBB.1.5 COVID-19 vaccine effectiveness against hospitalisations and deaths during the Omicron BA.2.86/JN.1 period among older adults in seven European countries: A VEBIS-EHR network study.

QR code

Sciensano info

Postal address

Relative vaccine effectiveness against COVID-19 hospitalisation in persons aged ≥ 65 years: results from a VEBIS network, Europe, October 2021 to July 2023.